Benefit of viral load testing for confirmation of immunological failure in HIV patients treated in rural Malawi.
AffiliationMédecins Sans Frontières, Chiradzulu, Malawi Monash Medical Centre, Clayton, Vic., Australia Epicentre, Paris, France Médecins Sans Frontières, Paris, France.
MetadataShow full item record
AbstractObjective Viral load testing is used in the HIV programme of Chiradzulu, Malawi, to confirm the diagnosis of immunological failure to prevent unnecessary switching to second-line therapy. Our objective was to quantify the benefit of this strategy for management of treatment failure in a large decentralized HIV programme in Africa. Methods Retrospective analysis of monitoring data from adults treated with first-line antiretroviral regimens for >1 year and meeting the WHO immunological failure criteria in an HIV programme in rural Malawi. The positive predictive value of using immunological failure criteria to diagnose virological failure (viral load >5000 copies/ml) was estimated. Results Of the 227 patients with immunological failure (185 confirmed with a repeat CD4 measurement), 155 (68.2%) had confirmatory viral load testing. Forty-four (28.4%) had viral load >5000 copies/ml and 57 (36.8%) >1000 copies/ml. Positive predictive value was 28.4% (95% CI 21.4-36.2%). Repeat CD4 count testing showed that 41% of patients initially diagnosed with immunological failure did no longer meet failure criteria. Conclusions Our results support the need for confirming all cases of immunological failure with viral load testing before switching to second-line ART to optimize the use of resources in developing countries.
- Diagnosis of antiretroviral therapy failure in Malawi: poor performance of clinical and immunological WHO criteria.
- Authors: van Oosterhout JJ, Brown L, Weigel R, Kumwenda JJ, Mzinganjira D, Saukila N, Mhango B, Hartung T, Phiri S, Hosseinipour MC
- Issue date: 2009 Aug
- Performance of immunological response in predicting virological failure.
- Authors: Ingole N, Mehta P, Pazare A, Paranjpe S, Sarkate P
- Issue date: 2013 Mar
- The role of targeted viral load testing in diagnosing virological failure in children on antiretroviral therapy with immunological failure.
- Authors: Davies MA, Boulle A, Technau K, Eley B, Moultrie H, Rabie H, Garone D, Giddy J, Wood R, Egger M, Keiser O, IeDEA Southern Africa Collaboration.
- Issue date: 2012 Nov
- Predictive factors for immunological and virological endpoints in Thai patients receiving combination antiretroviral treatment.
- Authors: Srasuebkul P, Ungsedhapand C, Ruxrungtham K, Boyd MA, Phanuphak P, Cooper DA, Law MG
- Issue date: 2007 Jan
- Second-line treatment in the Malawi antiretroviral programme: high early mortality, but good outcomes in survivors, despite extensive drug resistance at baseline.
- Authors: Hosseinipour MC, Kumwenda JJ, Weigel R, Brown LB, Mzinganjira D, Mhango B, Eron JJ, Phiri S, van Oosterhout JJ
- Issue date: 2010 Sep